Sodium-Glucose Cotransporter 2 Inhibitors Tied to Lower Kidney Stone Risk
THURSDAY, Feb. 8, 2024 -- For adults with type 2 diabetes, initiation of sodium-glucose cotransporter 2 inhibitors (SGLT2is) may lower the risk for nephrolithiasis, according to a study published online Jan. 29 in JAMA Internal Medicine.
Julie...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Diabetes | Diabetes Type 2 | Endocrinology | Internal Medicine | Kidney Stones | Pharmaceuticals | Sodium | Study | Urology & Nephrology